Medicinus : Jurnal Kedokteran
Vol 13, No 2 (2024): February

RNAi-Based Therapy: Prospect as Cancer Treatment

Soentoro, Samuel E (Unknown)
Timothy, Michael (Unknown)
Jo, Juandy (Unknown)

Article Info

Publish Date
13 Mar 2024

Abstract

Cancer is one of the deadliest form of diseases in humans, with the annual deaths ranging in the millions. Conventional treatments including chemotherapy, radiotherapy, or surgery has their limitations, including common off-target and non-specific effects. Ribonucleic acid interference (RNAi) offers a new strategy for treating cancer by silencing specific genes to prevent gene expression. This review highlights the application of RNAi-based approach in targeting cancer, discusses its potential advantages and limitations, summarizes the existing clinical trials and provides a greater understanding of RNAi-based therapy in cancer.

Copyrights © 2024




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
Medicinus : Jurnal Kedokteran
Website

Abbrev

Medicinus : Jurnal Kedokteran

Publisher

Universitas Pelita Harapan

Subject

Medicine & Pharmacology Public Health

Description

Medicinus: Jurnal Kedokteran is an official journal of the Faculty of Medicine, Universitas Pelita Harapan launched in the year 2007. Medicinus is a peer-reviewed and open-access journal that covers basic, translational, or clinical aspects of health and medical science. Medicinus accepts original ...